Neutralizing antibodies play a key role in protection against infection. They can also be leveraged in the laboratory to assess the effectiveness of antibody responses to infectious agents such as SARS-CoV-2. Bio-Rad’s Bio-Plex Pro Human SARS-CoV-2 Neutralization Antibody Assays provide quality and reliable results in less than three hours, compared to conventional cell-based assays that can take more than three days to produce results. Watch our webinar to learn more about the multiplex Bio-Plex Pro Human SARS-CoV-2 Neutralization Antibody Assays and how they can help researchers assess naturally acquired and vaccine-induced immunity to SARS-CoV-2 variants of concern.